NYSE:CCJ - Cameco Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$10.36 -0.06 (-0.58 %)
(As of 08/19/2018 01:14 PM ET)
Previous Close$10.36
Today's Range$10.26 - $10.44
52-Week Range$7.68 - $12.19
Volume968,127 shs
Average Volume2.15 million shs
Market Capitalization$4.26 billion
P/E Ratio86.33
Dividend Yield1.56%
Beta1.09
Cameco logoCameco Corporation produces and sells uranium worldwide. The company operates through three segments: Uranium, Fuel Services, and NUKEM. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrates. Its operating uranium properties include the Cigar Lake property located in Saskatchewan, Canada; the Inkai property situated in Kazakhstan; the Smith Ranch-Highland property located in Wyoming, the United States; and the Crow Butte property situated in Nebraska, the United States. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles and reactor components for CANDU reactors; and provides consulting services to CANDU operators. The NUKEM segment trades in uranium and uranium-related products. The company sells its uranium and fuel services to nuclear utilities. Cameco Corporation was founded in 1987 and is headquartered in Saskatoon, Canada.

Receive CCJ News and Ratings via Email

Sign-up to receive the latest news and ratings for CCJ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Miscellaneous metal ores
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CCJ
CUSIPN/A
Phone306-956-6200

Debt

Debt-to-Equity Ratio0.31
Current Ratio6.16
Quick Ratio3.58

Price-To-Earnings

Trailing P/E Ratio86.33
Forward P/E Ratio39.85
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.66 billion
Price / Sales2.47
Cash Flow$0.7301 per share
Price / Cash14.19
Book Value$9.47 per share
Price / Book1.09

Profitability

EPS (Most Recent Fiscal Year)$0.12
Net Income$-158,090,000.00
Net Margins-10.03%
Return on Equity1.61%
Return on Assets1.01%

Miscellaneous

Employees2,620
Outstanding Shares395,790,000
Market Cap$4.26 billion

Cameco (NYSE:CCJ) Frequently Asked Questions

What is Cameco's stock symbol?

Cameco trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCJ."

How often does Cameco pay dividends? What is the dividend yield for Cameco?

Cameco declared a quarterly dividend on Thursday, October 26th. Shareholders of record on Friday, December 29th will be given a dividend of $0.078 per share on Monday, January 15th. This represents a $0.31 annualized dividend and a dividend yield of 3.01%. The ex-dividend date is Thursday, December 28th. View Cameco's Dividend History.

How were Cameco's earnings last quarter?

Cameco Corp (NYSE:CCJ) released its quarterly earnings data on Wednesday, July, 25th. The basic materials company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.06. The basic materials company earned $333 million during the quarter, compared to the consensus estimate of $392.80 million. Cameco had a positive return on equity of 1.61% and a negative net margin of 10.03%. The firm's revenue for the quarter was down 29.1% on a year-over-year basis. During the same quarter last year, the company earned ($0.11) EPS. View Cameco's Earnings History.

When is Cameco's next earnings date?

Cameco is scheduled to release their next quarterly earnings announcement on Friday, October, 26th 2018. View Earnings Estimates for Cameco.

What price target have analysts set for CCJ?

5 brokers have issued twelve-month price objectives for Cameco's shares. Their forecasts range from $15.00 to $29.00. On average, they expect Cameco's share price to reach $20.00 in the next twelve months. This suggests a possible upside of 93.1% from the stock's current price. View Analyst Price Targets for Cameco.

What is the consensus analysts' recommendation for Cameco?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cameco in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cameco.

Who are some of Cameco's key competitors?

Who are Cameco's key executives?

Cameco's management team includes the folowing people:
  • Mr. Timothy S. Gitzel, Pres, CEO & Director (Age 55)
  • Grant E. Isaac, Sr. VP & CFO
  • Mr. Brian Arthur Reilly B.Sc., M.Sc., M.B.A., P.Geo., Sr. VP & COO
  • Mr. Sean Anthony Quinn, Sr. VP, Chief Legal Officer & Corp. Sec.
  • Ms. Alice Louise Wong, Sr. VP & Chief Corp. Officer

Has Cameco been receiving favorable news coverage?

News coverage about CCJ stock has been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cameco earned a news impact score of 0.20 on Accern's scale. They also gave news articles about the basic materials company an impact score of 47.25 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for Cameco.

Who are Cameco's major shareholders?

Cameco's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Beutel Goodman & Co Ltd. (5.60%), Caisse DE Depot ET Placement DU Quebec (3.32%), Global X Management Co LLC (2.06%), Vaughan Nelson Investment Management L.P. (1.60%), Exor Investments UK LLP (1.51%) and CIBC World Markets Inc. (1.20%).

Which institutional investors are selling Cameco stock?

CCJ stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Caisse DE Depot ET Placement DU Quebec, Letko Brosseau & Associates Inc., Commonwealth Bank of Australia, Brandes Investment Partners LP, Global X Management Co LLC, Beutel Goodman & Co Ltd. and Manning & Napier Group LLC.

Which institutional investors are buying Cameco stock?

CCJ stock was bought by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Connor Clark & Lunn Investment Management Ltd., Exor Investments UK LLP, Toronto Dominion Bank, Keybank National Association OH, Janus Henderson Group PLC, Tobam and Northpointe Capital LLC.

How do I buy shares of Cameco?

Shares of CCJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cameco's stock price today?

One share of CCJ stock can currently be purchased for approximately $10.36.

How big of a company is Cameco?

Cameco has a market capitalization of $4.26 billion and generates $1.66 billion in revenue each year. The basic materials company earns $-158,090,000.00 in net income (profit) each year or $0.12 on an earnings per share basis. Cameco employs 2,620 workers across the globe.

How can I contact Cameco?

Cameco's mailing address is 2121 11TH ST W, SASKATOON A9, S7M 1J3. The basic materials company can be reached via phone at 306-956-6200.


MarketBeat Community Rating for Cameco (NYSE CCJ)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  386 (Vote Outperform)
Underperform Votes:  367 (Vote Underperform)
Total Votes:  753
MarketBeat's community ratings are surveys of what our community members think about Cameco and other stocks. Vote "Outperform" if you believe CCJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CCJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.